** Shares of Emyria Ltd EMD.AX rise 32% to A$0.033, their highest since May 22
** The early-stage drug developer announces multi-year agreement with Medibank MPL.AX wherein the latter's customers can access EMD's s Empax PTSD care program
** EMD also raises A$4 million ($2.59 million) at A$0.024, a discount of 4% to the stock's last close
** Says proceeds will be used for programs under the Medibank agreement among others
** Stock set for best day since March 7, if gains hold
** Stock sees busiest session in over two years, as 12 mln shares change hands, 18.1x the 30-day average of 663,166
** MPL up 1.2% to A$4.96 for the session
** EMD down 2.9% YTD, including moves in current session
($1 = 1.5423 Australian dollars)
(Reporting by Jasmeen Ara Shaikh in Bengaluru)
((JasmeenAraIslam.Shaikh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.